loading

Avenue Therapeutics Inc Azioni (ATXI) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Research and Development
143.58%
2.392
0.982 0.907 3.027 1.215
Operating Income/Loss
74.99%
-3.708
-2.119 -2.068 -3.923 -6.429
Nonoperating Income/Loss
-0.641
- 2.581 -0.093 -1.173
Income/Loss From Continuing Operations Before Tax
804.86%
-4.349
0.617 0.513 -4.016 -7.602
Income/Loss From Continuing Operations After Tax
804.86%
-4.349
0.617 0.513 -4.016 -7.602
Net Income/Loss
804.86%
-4.349
0.617 0.513 -4.016 -7.602
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
60.87%
-0.009
-0.023 -0.013 -0.009 -0.066
Basic Average Shares
83.65%
0.562
3.4366 8.1142 - 5.5648
Basic Earnings Per Share
2,850%
-15.40
0.56 0.06 -0.52 -1.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$1.15
price up icon 6.48%
$31.19
price up icon 3.48%
$584.61
price up icon 1.98%
$306.09
price up icon 0.50%
$4.5994
price up icon 2.21%
$490.81
price up icon 0.11%
Capitalizzazione:     |  Volume (24 ore):